Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma

Ítems similars

• Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines
  per: Mohammadian, Mahshid, et al.
  Publicat: (2017)
• Antiangiogenic Agents in First-Line and Second-Line Therapy for Advanced Colorectal Cancer
  per: Bendell, Johanna
  Publicat: (2007)
• Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
  per: Feliu, J, et al.
  Publicat: (2010)
• Endobronchial valves: an emerging therapeutic alternative to VATS for the surgical management of advanced emphysema
  per: Kapoor, Shailendra
  Publicat: (2010)
• Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
  per: Hsu, C-H, et al.
  Publicat: (2010)